Management of late (>1 y) deep infection after spinal fusion: a retrospective cohort study

J Pediatr Orthop. 2015 Apr-May;35(3):266-70. doi: 10.1097/BPO.0000000000000252.

Abstract

Background: The incidence of late infection published in the literature varies from 1% to 12% with varying definition of late infection (range, 3 mo to 1 y). Current evidence suggests implant removal and antibiotic therapy is necessary to clear these infections. A high incidence of late (>1 y) deep infection after instrumented spinal fusion was identified at our institution. We sought to evaluate the efficacy of our management of these patients.

Methods: A total of 1390 patients underwent instrumented spinal fusion from 2000 to 2009. Forty-two patients developed deep infection >1 year after index procedure (3%) and had surgical debridement. Clinical records and microbiology reports were reviewed for details of operative and postoperative management.

Results: Advanced imaging was only obtained in 6 patients (5 computed tomography, 1 magnetic resonance imaging). Offending organisms were identified in 39/42 patients, 27 of these grew Propionibacterium acnes. P. acnes grew in culture at a median of 6 days (range, 3 to 10 d), significantly longer than all other organisms, which grew in a median of 1 day (range, 0 to 8 d) (P<0.001). Implants were removed at the index hospitalization in 41 patients. Implant retention was attempted in 1 patient and failed. Primary closure was carried out in 37 patients; the remainder had undergone multiple debridements (4 planned, 1 unplanned). VAC closure was utilized in 2 patients. All patients were treated with organism-specific intravenous antibiotics and transitioned to oral antibiotics on average in 34 days (range, 2 to 186 d). Total length of antibiotic therapy was an average of 141 days (range, 34 to 413 d).

Conclusions: P. acnes was the most common organism identified and took nearly 1 week to grow in culture. Treatment is generally successful with thorough debridement, removal of implants, and antibiotic treatment.

Level iii: retrospective comparative study.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Debridement
  • Device Removal
  • Female
  • Gram-Positive Bacterial Infections / complications
  • Gram-Positive Bacterial Infections / therapy*
  • Humans
  • Internal Fixators / adverse effects*
  • Male
  • Propionibacterium acnes*
  • Prosthesis-Related Infections / microbiology
  • Prosthesis-Related Infections / therapy*
  • Retrospective Studies
  • Spinal Fusion / adverse effects*
  • Spinal Fusion / instrumentation
  • Surgical Wound Infection / microbiology
  • Surgical Wound Infection / therapy*

Substances

  • Anti-Bacterial Agents